Skip to main content

The Globe and Mail

Valeant Pharmaceuticals Intl Inc (VRX-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 20.91
Day High 21.30
Open:20.98
Price movement based on the high, low and last over the given period.
Previous Close
Volume
Average Volume
Price/Earnings (TTM)
Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share ttm
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings ttm
Annual Dividend & Yield
Ex-Div Date
Price/Book
Most Recent Split

Financials

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

View the full Stock Reports+ PDF here

Latest Press Releases

Global Dermatology Diagnostic Devices Market Share will Increase more than US$ 5 Billion By 2026
Financeswire - Thu Nov 23, 7:22AM CST
Financeswire - CMTX
Thu Nov 23, 7:22AM CST
Global Aesthetic Devices Market is Determined to Cross US$ 18 Billion By 2023
Financeswire - Thu Nov 23, 4:56AM CST
Financeswire - CMTX
Thu Nov 23, 4:56AM CST
Valeant Announces Closing Of Add-On Secured Notes And Credit Agreement Amendment
PR Newswire - Tue Nov 21, 3:15PM CST
PR Newswire - CMTX
Tue Nov 21, 3:15PM CST
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has closed its previously announced offering (the "Offering") of $750,000,000 aggregate principal amount of its 5.500% senior secured notes due 2025 (the "Notes"). The Notes are additional notes and form part of the same series as Valeant's existing 5.500% senior secured notes due 2025. Valeant used the net proceeds from the offering of the Notes, along with cash on hand, to prepay (on a pro rata basis) a portion of its outstanding Series F Tranche B Term Loans due 2022 and to pay related fees and expenses.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 14.01 +50.68% increase
on 11/02/17
Period Open:15.39
Price movement based on the high, low and last over the given period.
21.46 -1.63% decrease
on 11/22/17
+5.72 (+37.17%) increase
since 10/24/17
3-Month 14.01 +50.68% increase
on 11/02/17
Period Open:18.44
Price movement based on the high, low and last over the given period.
21.46 -1.63% decrease
on 11/22/17
+2.67 (+14.48%) increase
since 08/24/17
52-Week 11.20 +88.48% increase
on 04/24/17
Period Open:23.50
Price movement based on the high, low and last over the given period.
23.75 -11.12% decrease
on 06/29/17
-2.39 (-10.17%) decrease
since 11/24/16

All market data is provided by Barchart Solutions (will open in new tab). Copyright © 2017.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement